Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nicotine interventions with comorbid populations.

Sharon M Hall1

  • 1Department of Health Psychology, University of California, San Francisco, San Francisco, California 94143-0984, USA. shall@lppi.ucsf.edu

American Journal of Preventive Medicine
|December 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Tobacco use behaviors and views on engaging in clinical trials for tobacco cessation among individuals who experience homelessness" [Contemporary Clinic. Trials Commun. 32 (2023) 101094].

Contemporary clinical trials communications·2025
Same author

Tobacco use behaviors and views on engaging in clinical trials for tobacco cessation among individuals who experience homelessness.

Contemporary clinical trials communications·2023
Same author

Contingency management to promote smoking cessation in people experiencing homelessness: Leveraging the electronic health record in a pilot, pragmatic randomized controlled trial.

PloS one·2022
Same author

Cigarette Smoking, Mental Health, and Other Substance Use among Court-Involved Youth.

Substance use & misuse·2019
Same author

Commentary on Laude et al. (2017): Extended treatment for cigarette smoking cessation.

Addiction (Abingdon, England)·2017
Same author

Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependency.

Drug and alcohol dependence·2017
Same journal

"The Real Cost" Campaign: Efficacy by Design.

American journal of preventive medicine·2026
Same journal

A Model for 21st Century Public Health Education: FDA's "The Real Cost" Youth Tobacco Prevention Campaigns.

American journal of preventive medicine·2026
Same journal

Fathers' adverse childhood experiences and children's behavior problems.

American journal of preventive medicine·2026
Same journal

Darknet cryptomarket listings for abortion medications after Dobbs.

American journal of preventive medicine·2026
Same journal

Modeling the Impact of Combined Individual and Population-level National strategies for preventing type 2 diabetes.

American journal of preventive medicine·2026
Same journal

Caregiving burden and health disparities: A nationwide study of 2,180 parents caring for children with developmental disabilities in South Korea.

American journal of preventive medicine·2026
See all related articles

Treating cigarette smoking in psychiatric and substance abuse patients is effective and safe. More research is needed for targeted prevention and treatment interventions in these vulnerable populations.

Area of Science:

  • Addiction Medicine
  • Psychiatry
  • Public Health

Background:

  • High prevalence of cigarette smoking among individuals with comorbid psychiatric and substance abuse disorders.
  • Limited research and interventions available for smoking cessation in these populations.
  • Barriers exist for implementing smoking cessation interventions.

Purpose of the Study:

  • To review and comment on existing studies of smoking treatment and prevention in comorbid populations.
  • To identify research gaps and recommend future directions.
  • To assess the efficacy and safety of smoking interventions in these groups.

Main Methods:

  • Literature review and commentary on existing studies.
  • Analysis of treatment efficacy and impact on abstinence from other substances.

Related Experiment Videos

  • Examination of intervention effects on psychiatric symptoms.

    • Main Results:

    • Smoking interventions are efficacious in substance abuse patients and do not hinder abstinence.
    • Limited but moderately effective data exists for psychiatric populations, with little harm.
    • Integration into existing clinics is desirable, but targeted prevention is lacking.

    Conclusions:

    • Existing smoking cessation treatments are reasonably effective and safe for individuals with psychiatric and substance abuse disorders.
    • Further research is crucial for both treatment and prevention strategies.
    • Targeted prevention efforts are needed for identified high-risk subgroups.